Table 1.

NP23 B-lineage ALL characteristics

IDAge, moSexMalignant immunophenotypeInfiltrated tissuesPeripheral blood CBC
WBC, ×109/LHgB, g/dLMCV, fLPLT, ×109/L
633 8.5 B220/CD19+/AA4.1+ BM, Spl, Liv, Kid 9.7 3.3 59.1 225 
724 7.75 B220lo/−/CD19+/AA4.1+ BM, Spl, LyNo, Thy, Liv, Kid 102.9 4.8 67.3 202 
752 5.75 B220/CD19+/AA4.1+ BM, Spl, LyNo, Thy, Liv, Kid 135.7 10.5 53.8 714 
758 10 B220/CD19+/AA4.1+ BM, Spl, LyNo 78.9 6.9 64.8 153 
CD4+/CD8+* Thy 
1450 B220/CD19+ BM, Spl, LyNo 34.84 7.1 87.5 92 
1533 B220/CD19+/AA4.1+ BM, Spl, LyNo, Liv nt    
1534 7.5 B220lo/−/CD19+/AA4.1 BM, Spl, LyNo, Thy, Liv, Kid nt    
CD4+/CD8+* BM, Spl, LyNo, Thy, Liv, Kid 
IDAge, moSexMalignant immunophenotypeInfiltrated tissuesPeripheral blood CBC
WBC, ×109/LHgB, g/dLMCV, fLPLT, ×109/L
633 8.5 B220/CD19+/AA4.1+ BM, Spl, Liv, Kid 9.7 3.3 59.1 225 
724 7.75 B220lo/−/CD19+/AA4.1+ BM, Spl, LyNo, Thy, Liv, Kid 102.9 4.8 67.3 202 
752 5.75 B220/CD19+/AA4.1+ BM, Spl, LyNo, Thy, Liv, Kid 135.7 10.5 53.8 714 
758 10 B220/CD19+/AA4.1+ BM, Spl, LyNo 78.9 6.9 64.8 153 
CD4+/CD8+* Thy 
1450 B220/CD19+ BM, Spl, LyNo 34.84 7.1 87.5 92 
1533 B220/CD19+/AA4.1+ BM, Spl, LyNo, Liv nt    
1534 7.5 B220lo/−/CD19+/AA4.1 BM, Spl, LyNo, Thy, Liv, Kid nt    
CD4+/CD8+* BM, Spl, LyNo, Thy, Liv, Kid 

BM, bone marrow; CBC, complete blood count; F, female; HgB, hemoglobin; Kid, kidney; Liv, liver; LyNo, lymph node; M, male; MCV, mean corpuscular volume; nt, not tested; Spl, spleen; Thy, thymus; WBC, white blood cell.

*

These 2 mice had concurrent pre-T LBL.

C10 line.